{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:59:17Z","timestamp":1791104357496,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ijrobp.2010.04.054","type":"journal-article","created":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T05:14:00Z","timestamp":1281676440000},"page":"1306-1315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["A Phase II Trial of Arc-Based Hypofractionated Intensity-Modulated Radiotherapy in Localized Prostate Cancer"],"prefix":"10.1016","volume":"80","author":[{"given":"Michael","family":"Lock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varagur","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Izawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.04.054_bib1","series-title":"Canadian cancer statistics 2008","author":"Marrett","year":"2008"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0360-3016(00)00620-9","article-title":"External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era","volume":"48","author":"Pollack","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib3","first-page":"111","article-title":"External beam radiotherapy dose response of prostate cancer","volume":"39","author":"Pollack","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib4","first-page":"46S","article-title":"Radical irradiation of localized prostate cancer: Prognosis and outcome based on clinical and biochemical assessment","author":"Mui","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0360-3016(95)00123-G","article-title":"The treatment of prostate cancer by conventional radiation therapy: An analysis of long-term outcome","volume":"32","author":"Zietman","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0169-5002(99)00019-7","article-title":"Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients","volume":"24","author":"Martel","year":"1999","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0360-3016(98)00089-3","article-title":"Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions","volume":"41","author":"Hanks","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib8","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib9","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ijrobp.2008.01.040","article-title":"Intensity-modulated radiotherapy as primary therapy for prostate cancer: Report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion","volume":"72","author":"Fonteyne","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0360-3016(02)02735-9","article-title":"Intensity modulated arc therapy simplified","volume":"53","author":"Wong","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0360-3016(02)02954-1","article-title":"Dose response in prostate cancer with 8-12 years' follow-up","volume":"54","author":"Hanks","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0360-3016(99)00455-1","article-title":"Higher than standard radiation doses (> or = 72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer","volume":"46","author":"Kupelian","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0360-3016(98)00091-1","article-title":"Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer","volume":"41","author":"Zelefsky","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib16","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2002.01.086","article-title":"Radical radiation for localized prostate cancer: Local persistence of disease results in a late wave of metastases","volume":"20","author":"Coen","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/cncr.11927","article-title":"The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer","volume":"100","author":"Jacob","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib18","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1001\/archinte.1996.00440180055007","article-title":"Cost of breast cancer treatment: A 4-year longitudinal study","volume":"156","author":"Legorreta","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.04.049","article-title":"Phase II trial of hypofractionated image-guided intensity modulated radiotherapy for localized prostate adenocarcinoma","volume":"69","author":"Martin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib20","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0360-3016(03)00752-1","article-title":"Hypofractionated conformal radiotherapy in carcinoma of the prostate: Five-year outcome analysis","volume":"57","author":"Livsey","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijrobp.2005.07.970","article-title":"Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial","volume":"64","author":"Pollack","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib22","series-title":"2005 Multidisciplinary Prostate Cancer Symposium\/Proceedings","first-page":"79","article-title":"A multi-institutional phase I\/II trial of hypofractionated radiation therapy for localized prostate cancer [Abstract]","author":"Ritter","year":"2005"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clon.2007.02.007","article-title":"Is the \u03b1\/\u03b2 value for prostate tumors low enough to be safely used in clinical trials?","volume":"19","author":"Dasu","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2005.06.009","article-title":"The \u03b1\/\u03b2 ratio for prostate cancer: What\u00a0is it, really? [editorial]","volume":"76","author":"Bentzen","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2006.12.036","article-title":"Use of individual fraction size data from 3756 patients to directly determine the \u03b1\/\u03b2 ratio of prostate cancer","volume":"68","author":"Williams","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0360-3016(02)04146-9","article-title":"Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: Early results of a Phase III randomized trial","volume":"55","author":"Yeoh","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib28","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijrobp.2006.06.005","article-title":"Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: Updated results of a phase III randomized trial","volume":"66","author":"Yeoh","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib29","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","article-title":"Randomized trial comparing two fractionation schedules for patients with localized prostate cancer","volume":"23","author":"Lukka","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib30","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ijrobp.2008.02.047","article-title":"Volumetric modulated arc therapy for delivery of prostate cancer radiotherapy: Comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy","volume":"72","author":"Palma","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1053-4296(99)80058-7","volume":"9","author":"Mackie","year":"1999","journal-title":"Tomotherapy. Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib32","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1088\/0031-9155\/40\/9\/004","article-title":"Intensity-modulated arc therapy with dynamic multileaf collimation: An alternative to tomotherapy","volume":"40","author":"Yu","year":"1995","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.meddos.2003.09.003","article-title":"Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy","volume":"29","author":"Bauman","year":"2004","journal-title":"Med Dosim"},{"issue":"1 Suppl","key":"10.1016\/j.ijrobp.2010.04.054_bib34","first-page":"S6","article-title":"A comparison of class solutions using arc and fixed beam intensity modulated radiotherapy for prostate cancer treatment","volume":"69","author":"Bauman","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib35","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0022-5347(17)35937-2","article-title":"The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer","volume":"150","author":"Roach","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib36","unstructured":"NCI Common Terminology Criteria for Adverse Events v3.0. 2006 http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf. Last accessed July 1, 2010."},{"key":"10.1016\/j.ijrobp.2010.04.054_bib37","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO phoenix consensus conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2010.04.054_bib38","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0167-8140(06)80774-7","article-title":"Hypofractionated prostate arc radiotherapy using ultrasound localization","volume":"80","author":"Lock","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ijrobp.2004.09.051","article-title":"Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer","volume":"62","author":"Cheung","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib40","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.ijrobp.2005.05.054","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long term outcomes","volume":"63","author":"Kupelian","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib41","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.radonc.2006.06.005","article-title":"Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity","volume":"80","author":"Soete","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib43","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijrobp.2007.12.041","article-title":"Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results","volume":"72","author":"Lim","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijrobp.2008.04.005","article-title":"Clinical and dosimetric predictors of acute toxicity after a 4-week hypofractionated external beam radiotherapy regimen for prostate cancer: Results from a multicentric prospective trial","volume":"73","author":"Arcangeli","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib45","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijrobp.2008.09.032","article-title":"Hypofractionated intensity-modulated radiotherapy for carcinoma of the prostate: Analysis of toxicity","volume":"74","author":"Coote","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijrobp.2008.10.050","article-title":"Toxicity assessment of pelvic intensity-modulated radiotherapy with hypofractionated simultaneous integrated boost to prostate for intermediate- and high-risk prostate cancer","volume":"75","author":"McCammon","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijrobp.2009.01.048","article-title":"Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy","volume":"76","author":"Pervez","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.04.054_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2009.06.022","article-title":"Don't squeeze hypofractionated schedules into too-short overall times","volume":"75","author":"Fowler","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610006681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610006681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:42:34Z","timestamp":1759743754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610006681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0360301610006681"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.04.054","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase II Trial of Arc-Based Hypofractionated Intensity-Modulated Radiotherapy in Localized Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.04.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}